NCT05123092

Brief Summary

The study design will be double blinded retrospective controlled comparative study. The patients will be included in the study shoud be in the following category:

  • American Society of Anesthesiologists (ASA) physical status I, II
  • Age range from 18 and 70 years. The patients will be discarded from the study shoud be in the following:
  • patient refusal.
  • significant renal, hepatic and cardiovascular diseases.
  • Pregnancy.
  • Any contraindication to regional anesthesia such as local infection or bleeding disorders.
  • Chronic opioid use, history of chronic pain and cognitive disorders.
  • Lumbar spine lesion revision and dural tear. Postoperative pain will be evaluated using a visual analogue scale (VAS) score as primary outcome measure. demographic data ( Age, Weight, sex and height) , ASA classification ,mean operative times (min), time to the first rescue analgesic (min) ,intraoperative fentanyl consumption(microgram),postoperative opioid consumption ,sedation score, hemodynamics intraoperative and postoperative ( BP ,H R and oxgen saturation %) and complications as 2ry outcome measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 13, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 17, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2022

Completed
Last Updated

June 7, 2022

Status Verified

June 1, 2022

Enrollment Period

1 year

First QC Date

August 13, 2021

Last Update Submit

June 4, 2022

Conditions

Keywords

UltrsoundIntrathecalMorphineErectae spinae

Outcome Measures

Primary Outcomes (1)

  • VAS score

    The mean VAS score (score 0 =no pain and 10 =worst pain ever ) in the two groups of the study.

    Every 4 bours for 48 hours post operative

Secondary Outcomes (12)

  • Age

    Day 1

  • Gender

    Day 1

  • Height

    Day 1

  • Weight

    Day 1

  • Body Mass Index

    Day 1

  • +7 more secondary outcomes

Study Arms (2)

Group ( ultrasound guided erectae spinae block)

ACTIVE COMPARATOR

The same anesthesiologist who is experienced in US guided regional anesthesia will perform the block. In the group ESP, a high frequency linear US probe (HFL\_50, 15\_6MHz) will be placed vertically and nearly 3 cm lateral to the vertebra in the middle of the incision line. The transverse process and the overlaying erector spinae muscles (ESM) will be identified under parasagittal scanning A22 G,50 mm block needle (SONOTAP,Pajunk, Geisingen,Germany) will be inserted at a 30-40° angle in the cranial to caudal direction via an in-plane approach and advanced into the plane between the fascia of ESM and transverse process under sterile conditions. The correct needle position will be confirmed after a hydro dissection with 3 ml of isotonic saline, and then 20 ml of 0.25% bupivacaine will be injected in the interfascial plane between the rhomboideus major muscle and ESM. The local anesthetic spread will be visualized in a fascial longitudinal pattern deep to the ESM.

Other: Ultrasound guided lumbar erectae spinae blockOther: Intrathecal Morphine injection

Group (Intrathecal morphine)

ACTIVE COMPARATOR

In the group of intrathecal morphine , a lumbar puncture will be done in the lateral position via a midline approach into the level of the vertebra which exists in the middle of the incision with complete aseptic condition using 25 gauge Quincke spinal needle to give 0.3 mg of morphine (preservative free form) suspended in 0.4 ml of normal saline .

Other: Ultrasound guided lumbar erectae spinae blockOther: Intrathecal Morphine injection

Interventions

One group by using ultrasound for making erectae spinae block

Group ( ultrasound guided erectae spinae block)Group (Intrathecal morphine)

Injecting intrathecal morphine

Group ( ultrasound guided erectae spinae block)Group (Intrathecal morphine)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I, II patients who will be scheduled for elective lumbar surgery for one or two levels. • Age range from 18 and 70 years.

You may not qualify if:

  • patient refusal.
  • significant renal, hepatic and cardiovascular diseases.
  • History of allergy to one of the study drugs.
  • Pregnancy.
  • Any contraindication to regional anesthesia such as local infection or bleeding disorders.
  • Chronic opioid use, history of chronic pain and cognitive disorders.
  • Lumbar spine lesion revision and dural tear.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atef Mohamed mahmoud

Al Fayyum, 63511, Egypt

Location

Related Publications (1)

  • Mahmoud AM, Ragab SG, Shawky MA, Masry DH, Botros JM. The Efficacy of Erector Spinae Plane Block Compared With Intrathecal Morphine in Postoperative Analgesia in Patients Undergoing Lumbar Spine Surgery: A Double-blind Prospective Comparative Study. Pain Physician. 2023 Mar;26(2):149-159.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization will be done via computer-generated random numbers that will be placed in separate closed envelopes and will be opened by study investigators just after induction of general anesthesia. Neither the patients, the study investigators, the attending clinicians nor the data collectors will be aware of the allocation of groups till the study ends.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The patients will be allocated in 1:1 ratio to one of the two groups: group erector spinae plane block (n=41), and group intrathecal morphine (n=41).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 13, 2021

First Posted

November 17, 2021

Study Start

January 20, 2021

Primary Completion

January 20, 2022

Study Completion

January 20, 2022

Last Updated

June 7, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Upon finishing my study and publishing an article, I will share my data upon resonable rquest.

Locations